CASI Pharmaceuticals Inc.:
Received MNPA (f.k.a. CFDA) approval for EVOMELA® (melphalan for injection: multiple myeloma) on Dec 3, 2018; CFDA review in progress for ZEVALIN® and MARQIBO® (in-licensed from Spectrum Pharma). Acqd 25 US FDA-approved ANDAS from Sandoz in Jan 2018.
100MM - 500MM
9620 Medical Center Drive
Rockville, MD 20850
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Hamptons CEO Roundtable 2019
August 15, 2019
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by